Cover Image

Budget capacite of Ukraine for financing of COVID-19 vaccination in the emerging global vaccine market

Saved in:

Bibliographic Details
Date:	2021
Main Authors:	V. M. Heiets, I. O. Lunina, O. V. Stepanova
Format:	Article
Language:	English
Published:	2021
Series:	Economy of Ukraine
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0001264073
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Molecular Characteristics of Blood Serum After Covid-19 Vaccination in a Remote Period
by: Pedachenko, Y.E., et al.
Published: (2024)

Optimal control strategy for the administration of the third vaccine dose in the treatment of pandemic COVID-19
by: I. Khaloufi, et al.
Published: (2023)

The Formation of Fiscal Space While Overcoming Vaccine Nationalism and Ensuring Sustainability of Development
by: V. Heyets, et al.
Published: (2021)

The legal basis for the compulsory vaccination of higher education institutions&#039; staff in the COVID-19 pandemic
by: N. S. Khatniuk, et al.
Published: (2022)

Characterization of vaccine and field IBDV strains in Ukraine for proper vaccine selection for disease prevention
by: Pastyria, A.S., et al.
Published: (2018)

Prognosis of RNA, siRNA, Followed by the Immunological Response of the Proposed Vaccine (Vac534) against COVID-19
by: Dawood, A.A., et al.
Published: (2024)

COVID-19 infection: disease mechanism, vascular dysfunction, immune responses, markers, multiorgan failure, treatments, and vaccination
by: S. G. Vari
Published: (2020)

Antiproteases vaccine the flu in the experiment
by: V. A. Divocha
Published: (2015)

On the participation of scientists of the NAS of Ukraine in counteracting COVID-19. Development of vaccines against SARS-CoV-2 and COVID-19 in Ukraine: Status, problems and prospects (transcript of report at the meeting of the Presidium of NAS of Ukraine,
by: S. V. Komisarenko
Published: (2021)

Coronavirus S antigen as a marker of effective vaccination
by: V. H. Spyrydonov, et al.
Published: (2021)

Biotechnological research in the creation and production of antirabic vaccines
by: Yu. M. Krasnopolsky, et al.
Published: (2021)

An epidemic model with viral mutations and vaccine interventions
by: Y. A. Adi, et al.
Published: (2023)

New inactivated vaccine against enzootic encephalomyelitis of swines
by: S. V. Derevianko, et al.
Published: (2013)

The anticancer efficiency of the xenogeneic vaccine and the indication for its use
by: T. V. Symchych, et al.
Published: (2014)

Optimal vaccination strategy in the stochastic epidemic limited-treatment model
by: O. V. Bohdanov
Published: (2022)

Modelling the Optimal Schemes of Population Vaccination Using Epidemiological Data
by: S. Soloviov, et al.
Published: (2019)

Modelling the Optimal Schemes of Population Vaccination Using Epidemiological Data
by: Soloviov, S., et al.
Published: (2020)

The presence of host cellular components in vaccines and immunobiological blood preparations
by: V. A. Divocha
Published: (2016)

Experimental study of the efficacy of combined use of cancer vaccine and interferon
by: Potebnya, G.P., et al.
Published: (2007)

Substantiation of the diffusion model for innovation implementation and its application to the spread of vaccinations
by: V. M. Horbachuk, et al.
Published: (2022)

Effect of standard and low temperature-modified glycopeptide vaccines on tumour process in experiment
by: O. P. Kuzmenko, et al.
Published: (2005)

Approaches to designing of new generation vaccines against the sheep pox disease
by: E. F. Yilmaz, et al.
Published: (2016)

Influence of introduction of interleukin-2 and interleukin-12 into experimental marker DNA-vaccine
by: Ya. O. Pokholenko, et al.
Published: (2019)

Anticancer effectiveness of vaccination based on xenogeneic embryo proteins applied in different schedules
by: T. V. Symchych, et al.
Published: (2015)

COVID-19 pandemic and fiscal sustainability
by: O. V. Stepanova
Published: (2020)

Influence of hepatitis A in the period of recoveryon maintaining post-vaccination immunity to diphtheria
by: A. S. Podorozhnaja, et al.
Published: (2013)

Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)

Comparison of the efficacy of different regimens of xenogeneic cancer vaccine on models of metastatic tumor growth
by: N. I. Fedosova, et al.
Published: (2017)

Global Trends and Initiatives in Forming the Green Bonds Market in the Context of COVID-19
by: N. V. Dunas
Published: (2021)

Antitumor and antimetastatic efficiency of antitumor vaccine and amixin combined action in mice with Lewis lung carcinoma
by: G. V. Didenko, et al.
Published: (2016)

Vaccination against high carcinogenic types of the human papillomavirus in the prevention of cervical cancer: Realities in Western Ukraine
by: L. Kostiuchenko, et al.
Published: (2018)

Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma
by: Zhuravel, E., et al.
Published: (2010)

Data processing algorithms for the in silico SARS-CoV-2 epitope prediction and vaccine development
by: M. Sprindzuk, et al.
Published: (2021)

Main causes of development of bcg vaccination complications and accuracy of the investigation of the cellular problem of immunity in their diagnosis
by: N. A. Matsehora, et al.
Published: (2018)

Cytotoxic activity of immune cells following administration of xenogeneic cancer vaccine in mice with melanoma B-16
by: N. I. Fedosova, et al.
Published: (2015)

The Impact of the COVID-19 Pandemic on the State of the Labor Market in Ukraine
by: O. V. Shavurska
Published: (2022)

The world after COVID-19: global challenges of the development
by: Ya. Krasivskyi
Published: (2021)

The Impact of the COVID-19 Pandemic on Regional Labor Markets in Ukraine
by: O. M. Levanda, et al.
Published: (2022)

Action of booster immunization with E2 CSFV on immune response elicited by marker DNA-vaccine against CSF
by: Ia. O. Pokholenko, et al.
Published: (2012)

Immunological markers of anti-tumor dendritic cells vaccine efficiency in patients with non-small cell lung cancer
by: O. V. Skachkova, et al.
Published: (2013)